VHAM
LMAT icon

Van Hulzen Asset Management’s LeMaitre Vascular LMAT Stock Holding History

Van Hulzen Asset Management’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$959K Sell
9,991
-1,803
-15% -$185K 0.07% 181
2026
Q1 		$1.29M Sell
11,794
-6,619
-36% -$631K 0.1% 133
2025
Q4 		$1.49M Sell
18,413
-1,737
-9% -$150K 0.11% 125
2025
Q3 		$1.76M Sell
20,150
-740
-4% -$66.1K 0.13% 115
2025
Q2 		$1.73M Sell
20,890
-2,474
-11% -$207K 0.14% 113
2025
Q1 		$1.96M Sell
23,364
-970
-4% -$90.2K 0.18% 103
2024
Q4 		$2.24M Buy
24,334
+1,576
+7% +$152K 0.16% 101
2024
Q3 		$2.11M Buy
22,758
+8,186
+56% +$709K 0.15% 109
2024
Q2 		$1.2M Buy
14,572
+582
+4% +$42.8K 0.08% 143
2024
Q1 		$928K Sell
13,990
-9,314
-40% -$575K 0.06% 175
2023
Q4 		$1.32M Buy
23,304
+9,992
+75% +$523K 0.09% 135
2023
Q3 		$725K Buy
13,312
+4,259
+47% +$252K 0.06% 180
2023
Q2 		$609K Sell
9,053
-5,569
-38% -$340K 0.05% 164
2023
Q1 		$753K Buy
14,622
+2,452
+20% +$119K 0.07% 139
2022
Q4 		$560K Buy
12,170
+484
+4% +$22.7K 0.06% 159
2022
Q3 		$592K Buy
11,686
+537
+5% +$26.8K 0.07% 153
2022
Q2 		$508K Buy
11,149
+223
+2% +$9.97K 0.06% 165
2022
Q1 		$508K Buy
10,926
+1,525
+16% +$68.2K 0.05% 169
2021
Q4 		$472K Buy
9,401
+1,842
+24% +$95.2K 0.05% 185
2021
Q3 		$401K Buy
7,559
+25
+0.3% +$1.41K 0.06% 178
2021
Q2 		$460K Buy
+7,534
New +$400K 0.07% 162

Other funds holding LMAT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Van Hulzen Asset Management's LMAT Position: Q2 2026 in Review

Van Hulzen Asset Management reduced its LeMaitre Vascular (LMAT) stake by 15% in Q2 2026, selling an estimated $185K and leaving 9,991 shares worth $959K. The position accounts for 0.07% of the portfolio, ranked #181.

Van Hulzen Asset Management first reported a position in LMAT in Q2 2021 and has held it in 21 quarters since. The position peaked at $2.24M in Q4 2024. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

  • Van Hulzen Asset Management held 9,991 shares of LeMaitre Vascular worth $959K as of Q2 2026.
  • Van Hulzen Asset Management sold 1,803 LeMaitre Vascular shares in Q2 2026, an estimated $185K.
  • LeMaitre Vascular made up 0.07% of Van Hulzen Asset Management's portfolio in Q2 2026, its #181 holding.
  • Van Hulzen Asset Management first reported a position in LeMaitre Vascular in Q2 2021 and has held it in 21 quarters since.
  • Van Hulzen Asset Management's LeMaitre Vascular position peaked at $2.24M in Q4 2024.
  • 326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Van Hulzen Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.